High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer.
Yuqing ShenHui LinKelie ChenWanzhong GeDajing XiaYihua WuWei-Guo LvPublished in: Journal of ovarian research (2022)
Our studies suggested that high expression of RIPK2 is related to Taxol resistance in serous ovarian cancer, and that RIPK2 induces Taxol resistance through NOD1/RIPK2/NF-κB inflammatory pathway activation and tumor microenvironment changes.